Search 

Enterika Ltd is the first company to be supported by the QMIF. The company is developing weight-loss products aimed at tackling obesity, which is a significant risk factor for a range of chronic diseases. Enterika was successful with securing an Innovate UK grant to further develop the technology and has the support and interest from several investors.

Selcia is a global contract research provider of integrated drug discovery, medicinal chemistry and 14C radiolabeled compounds. Established in 2001, the company has two divisions: Selcia Drug Discovery - with medicinal chemistry,biology ADME and a unique peptidyl proyl isomerase (PPIase) inhibitor screening platform; and Selcia Radiolabeling - one of the world’s largest suppliers of custom 14C radiochemicals.